Darrigo Joseph (47 results)

Hardcover. Condition: Wie neu. 2nd ed. 344 S.; Ill. Like new. Shrink wrapped. Sprache: Englisch Gewicht in Gramm: 915.

Condition: Gebraucht / Used. Als nieuw d1118e.

Paperback. Condition: Brand New. 84 pages. 8.66x5.91x0.19 inches. In Stock.

Condition: good. A copy that has been read, remains in good condition. All pages are intact, and the cover is intact. The spine and cover show signs of wear. Pages can include notes and highlighting and show signs of wear, and the copy can include "From the library of" labels or previous owner inscriptions. 100% GUARANTEE! Shipped with delivery confirmation, if you're not satisfied with purchase please return item! Ships via media mail.…

Condition: New.

Taschenbuch. Condition: Neu. Dementia Confidential: Aiming for Normal Aging, versus Dementia | Joseph D'Arrigo | Taschenbuch | 84 S. | Englisch | 2018 | LAP LAMBERT Academic Publishing | EAN 9786139936663 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.…

Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Condition: New.

Condition: New. pp. xx + 415 1st Edition.

Condition: New. pp. xx + 415 Illus.

Condition: New. pp. xx + 415.

Condition: New.

Condition: As New. Unread book in perfect condition.

Condition: New. In English.

Condition: New.

Condition: As New. Unread book in perfect condition.

Hardback. Condition: New. This title is a greatly expanded and updated second edition of the original volume published by Elsevier in 1986. New material has been integrated with the original content in an organized and comprehensive manner. Five new chapters have been included, which review over one and a half decades of research into lipid-coated microbubbles (LCM) and their medical applications. The new chapters contain much experimental data, which is examined in detail, along with relevant current literature. This current edition builds on the original work in effectively filling the gap in the market for a comprehensive account of the surfactant stabilization of coated microbubbles.…

Condition: New. Presents updated results from extensive multidisciplinary research on coated microbubbles Greatly expanded and updated 2nd edition, with five new chapters Fills the gap for a comprehensive and up-to-date account of subject matter.

Hardback. Condition: New. This title is a greatly expanded and updated second edition of the original volume published by Elsevier in 1986. New material has been integrated with the original content in an organized and comprehensive manner. Five new chapters have been included, which review over one and a half decades of research into lipid-coated microbubbles (LCM) and their medical applications. The new chapters contain much experimental data, which is examined in detail, along with relevant current literature. This current edition builds on the original work in effectively filling the gap in the market for a comprehensive account of the surfactant stabilization of coated microbubbles.…

Condition: New.

Condition: New.

Hardcover. Condition: Very Good. Same / next day dispatch (Monday - Friday).

Condition: Gut. Zustand: Gut | Sprache: Deutsch | Produktart: Bücher | In den letzten Jahrzehnten wurde eine häufige Koexistenz von zerebrovaskulärer Pathologie und Alzheimer-Krankheitspathologie beobachtet. Dementsprechend gibt es zahlreiche Belege dafür, dass eine mikrovaskuläre endotheliale Dysfunktion, die auf zerebrovaskuläre Risikofaktoren (z. B. Atherosklerose, Fettleibigkeit, Diabetes, Rauchen, Bluthochdruck, Alterung) zurückzuführen ist, dem kognitiven Verfall bei der Alzheimer-Krankheit vorausgeht und zu ihrer Pathogenese beiträgt. In diesem Buch wird ein Multitasking-Kombinationstherapeutikum (d. h. ein biomimetischer Lipid-Nanoträger für mehrere Arzneimittel) beschrieben, das die Blut-Hirn-Schranke überwindet und leicht an Populationen von Scavenger-Rezeptoren an der Zelloberfläche (hauptsächlich SR-BI) gleichzeitig im Gehirngewebe bindet. Es wurde vielfach berichtet, dass dieselben Rezeptorklassen auf verschiedenen Zelltypen, die mit der Alzheimer-Krankheit in Zusammenhang stehen, in großer Zahl vorkommen. Daher könnte dieses Multitasking-Therapeutikum (mit gezielter Wirkstoffabgabe) auch eine größere Wirksamkeit in verschiedenen Stadien der Alzheimer-Krankheit aufweisen. Ein solcher Multitasking-Therapieansatz könnte besonders für Pharmaforscher, Studenten und Mediziner von Nutzen sein, da er einen vielversprechenden Weg zur Behandlung, Verzögerung oder sogar Vorbeugung der Krankheit in der Zukunft darstellt.…

Condition: Hervorragend. Zustand: Hervorragend | Sprache: Deutsch | Produktart: Bücher | In den letzten Jahrzehnten wurde eine häufige Koexistenz von zerebrovaskulärer Pathologie und Alzheimer-Krankheitspathologie beobachtet. Dementsprechend gibt es zahlreiche Belege dafür, dass eine mikrovaskuläre endotheliale Dysfunktion, die auf zerebrovaskuläre Risikofaktoren (z. B. Atherosklerose, Fettleibigkeit, Diabetes, Rauchen, Bluthochdruck, Alterung) zurückzuführen ist, dem kognitiven Verfall bei der Alzheimer-Krankheit vorausgeht und zu ihrer Pathogenese beiträgt. In diesem Buch wird ein Multitasking-Kombinationstherapeutikum (d. h. ein biomimetischer Lipid-Nanoträger für mehrere Arzneimittel) beschrieben, das die Blut-Hirn-Schranke überwindet und leicht an Populationen von Scavenger-Rezeptoren an der Zelloberfläche (hauptsächlich SR-BI) gleichzeitig im Gehirngewebe bindet. Es wurde vielfach berichtet, dass dieselben Rezeptorklassen auf verschiedenen Zelltypen, die mit der Alzheimer-Krankheit in Zusammenhang stehen, in großer Zahl vorkommen. Daher könnte dieses Multitasking-Therapeutikum (mit gezielter Wirkstoffabgabe) auch eine größere Wirksamkeit in verschiedenen Stadien der Alzheimer-Krankheit aufweisen. Ein solcher Multitasking-Therapieansatz könnte besonders für Pharmaforscher, Studenten und Mediziner von Nutzen sein, da er einen vielversprechenden Weg zur Behandlung, Verzögerung oder sogar Vorbeugung der Krankheit in der Zukunft darstellt.…

Hardcover. Condition: New. Ship out in 2 business day, And Fast shipping, Free Tracking number will be provided after the shipment.Pub Date: 2012 Publisher: Science Press Note: If you are required to book the number is greater than the bookstore inventory you can promptly inform the dispensers Tel 15801427360 Contact qq 794153166 (Send staples bibliography). place in bookstores internal transfer cargo 1-2 days. The OUR Books brand new genuine absolute guarantee. when you sign must seriously view the parcel. satisfaction after receipt books. not satisfied directly refusal. this can save Returns cost and time. the problems caused due to reasons of bookstores all unconditional return policy. Thank you for your visit. Assured orders to ensure that your shopping smooth look forward to your good basic information about the title: stable nanoemulsions: self-assembly in nature and nano-medicine (Navigation Edition) List Price: 138.00 yuan Author: Joseph D. Arrigo (Joseph D ' Arrigo) Publisher: Science Press Publication Date: May 1. 2012 ISBN: 9.787.030.342.188 words: Page: Revision: 1 Binding: Hardcover Folio: 16 commodity identification: B008A49YSW Editor Recommended stable nanoemulsions: in nature and the self-assembly of nano-medicine (Navigation Edition) stable oil molecules nanoemulsions recent progress in the field of nano-medicine. Of applications LCM system technology has a wealth of practical experience in the medical field. Focus on the basis of a combination of cutting-edge. and an emphasis on scientific research and practice. with a large number of references. Chemical engineering. polymer materials. medicine and other fields related to read reference. Abstract No 1.1.2 sound of the importance of the presence of low concentrations of a natural water gas - liquid emulsion 1.1 stable microbubbles 1.1.1 Contents Preface Part biosphere natural coated microbubbles hydrodynamic cavitation. hydraulic and ocean engineering 1.1.3 Wastewater Treatment: the micro flotation 1.1.4 marine biology. chemical oceanography 1.1.5 meteorology 1.2 background observation 1.2.1 nucleate gap model 1.2.2 through selected surfactant monolayer structure cavitation reduce the gas through the gas-liquid interface diffusion 1.3 freshwater membrane stabilizing microbubbles prove 1.3.1 acoustic measuring the 1.3.2 light scattering measurements 1.3.3 Gas Diffusion to test 1.4 seawater membrane stability microbubbles prove 1.4.1 acoustic measuring 1.4. add dilute electrolyte and pH changes in progress 2.2 2 2 water-soluble carbohydrate gel 1.4.3 optical light scattering measurements to verify previous work 2.1 agarose gel method to simulate bubbles formed agarose gel in 2.3 agarose gel concentrated is added to the electrolyte. and 1% of phenol 2.4 Physico-chemical literature published in the detailed comparison of the data is used for the salting-out of the non-ionic surface active agents identified 2.5 Conclusion 3 water phase of the soil extract and carbohydrate gel Comparative 3.1 soil and agarose powder * The possibility microbubbles residue was 3.2 (filtered) water phase soil extract applies to the effect of bubble formation in the agarose gel method 3.3 commercial agarose and soil extract indene 3.4 methylene blue photochemical experiment 3.5 2 - hydroxy - 5 - nitrobenzyl bromide experiment 3.6 Conclusion 4 natural micro-foam surfactants characterized glycopeptide Score 4.1 Analysis Method 4.1.1 commercial agarose and forest soils microbubbles glycopeptide surface active agent isolation 4.1.2 agar Amino acid analysis of a reduced pressure of a sugar gel test 4.1.3 isolated glycopeptide surfactant 4.1.4 sodium dodecyl sulfate / polyacrylamide gel electrophoresis 4.1.5 portion of the surface of the purified glycopeptide active agent carbohydrates Analysis 4.1.6 Glycopeptide surfactant gel column chromatography 4.1.7 Edman degradation analysis 4.2 biochemical results 4.2.1 agarose gel protein extraction and bubbles generated 4.2.2 microbubbles glycopeptide class The amino acid co.…

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -A frequent coexistence of cerebrovascular pathology and Alzheimer's disease pathology has been observed over past decades. Accordingly, there is much documentary evidence indicating that microvascular endothelial dysfunction, due to cerebrovascular risk factors (e.g., atherosclerosis, obesity, diabetes, smoking, hypertension, aging), precedes cognitive decline in Alzheimer's disease and contributes to its pathogenesis. This book describes a multitasking combination therapeutic (i.e., biomimetic lipid nanocarrier for several drugs) which crosses the blood-brain barrier, and readily binds to populations of cell-surface scavenger receptors (mainly SR-BI) simultaneously in brain tissue. These same receptor classes have been extensively reported to occur prominently on various Alzheimer's-related cell types. Hence, this multitasking (targeted drug-delivery) therapeutic may also display greater effectiveness at different stages of Alzheimer's disease. Such a multitasking therapeutic approach could be especially useful to pharmaceutical researchers, graduate students and medical professionals by representing a promising way to treat, delay, or even prevent the disease in the future. 84 pp. Englisch.…

Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -En las últimas décadas se ha observado una coexistencia frecuente de patología cerebrovascular y patología de la enfermedad de Alzheimer. En consecuencia, existen numerosas pruebas documentales que indican que la disfunción endotelial microvascular, debida a factores de riesgo cerebrovascular (por ejemplo, aterosclerosis, obesidad, diabetes, tabaquismo, hipertensión, envejecimiento), precede al deterioro cognitivo en la enfermedad de Alzheimer y contribuye a su patogénesis. Este libro describe una combinación terapéutica multitarea (es decir, un nanotransportador lipídico biomimético para varios fármacos) que atraviesa la barrera hematoencefálica y se une fácilmente a poblaciones de receptores carroñeros de superficie celular (principalmente SR-BI) de forma simultánea en el tejido cerebral. Se ha informado ampliamente de que estas mismas clases de receptores ocupan un lugar destacado en varios tipos de células relacionadas con la enfermedad de Alzheimer. Por lo tanto, esta terapia multitarea (de administración selectiva de fármacos) también puede ser más eficaz en las distintas fases de la enfermedad de Alzheimer. Este enfoque terapéutico multitarea podría ser especialmente útil para investigadores farmacéuticos, estudiantes de posgrado y profesionales de la medicina, ya que representa una forma prometedora de tratar, retrasar o incluso prevenir la enfermedad en el futuro. 72 pp. Spanisch.…

Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - A frequent coexistence of cerebrovascular pathology and Alzheimer's disease pathology has been observed over past decades. Accordingly, there is much documentary evidence indicating that microvascular endothelial dysfunction, due to cerebrovascular risk factors (e.g., atherosclerosis, obesity, diabetes, smoking, hypertension, aging), precedes cognitive decline in Alzheimer's disease and contributes to its pathogenesis. This book describes a multitasking combination therapeutic (i.e., biomimetic lipid nanocarrier for several drugs) which crosses the blood-brain barrier, and readily binds to populations of cell-surface scavenger receptors (mainly SR-BI) simultaneously in brain tissue. These same receptor classes have been extensively reported to occur prominently on various Alzheimer's-related cell types. Hence, this multitasking (targeted drug-delivery) therapeutic may also display greater effectiveness at different stages of Alzheimer's disease. Such a multitasking therapeutic approach could be especially useful to pharmaceutical researchers, graduate students and medical professionals by representing a promising way to treat, delay, or even prevent the disease in the future.…

Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Au cours des dernières décennies, on a observé une coexistence fréquente de la pathologie cérébrovasculaire et de la pathologie de la maladie d'Alzheimer. En conséquence, de nombreuses preuves documentaires indiquent que le dysfonctionnement endothélial microvasculaire, dû à des facteurs de risque cérébrovasculaires (athérosclérose, obésité, diabète, tabagisme, hypertension, vieillissement), précède le déclin cognitif dans la maladie d'Alzheimer et contribue à sa pathogenèse. Ce livre décrit une combinaison thérapeutique multitâche (c'est-à-dire un nanocarrier lipidique biomimétique pour plusieurs médicaments) qui traverse la barrière hémato-encéphalique et se lie facilement à des populations de récepteurs de piégeage à la surface des cellules (principalement SR-BI) simultanément dans le tissu cérébral. Ces mêmes classes de récepteurs ont été largement signalées comme étant présentes de manière proéminente sur divers types de cellules liées à la maladie d'Alzheimer. Par conséquent, cette thérapie multitâche (délivrance ciblée de médicaments) peut également se révéler plus efficace à différents stades de la maladie d'Alzheimer. Une telle approche thérapeutique multitâche pourrait être particulièrement utile aux chercheurs pharmaceutiques, aux étudiants de troisième cycle et aux professionnels de la santé en représentant un moyen prometteur de traiter, de retarder ou même de prévenir la maladie à l'avenir. 76 pp. Französisch.…